Amsan Variant of Guillain-Barresyndrome: A Case Report
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064

Amsan Variant of Guillain-Barresyndrome: A Case Report

Anzon John

Abstract: Guillain- Barré syndrome (GBS) is a rare and potentially life-threatening medical condition resulting from an individual’s immune system’s attack on the peripheral nerves. It is the result of an auto-immune response leading to axonal degeneration or demyelination. Acute motor and sensory axonal neuropathy (AMSAN) is a variant of GBS with the poorest prognosis. It is characterized by rapid-onset motor weakness, loss of deep tendon reflexes and sensory changes. Immunotherapy is considered a standard treatment for GBS. Here, the reported case is of AMSAN variant of GBS in a 42-year-old patient, who developed bilateral facial nerve palsy and treated with intravenous immunoglobulin (IVIg).

Keywords: immune system, deep-tendon reflexes, lower and upper limbs, muscle movement

How to Cite?: Anzon John, "Amsan Variant of Guillain-Barresyndrome: A Case Report", Volume 8 Issue 8, August 2019, International Journal of Science and Research (IJSR), Pages: 1955-1957, https://www.ijsr.net/getabstract.php?paperid=ART2020801, DOI: https://dx.doi.org/10.21275/ART2020801

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.